TB or not TB: Treat to see [3]

Medical Journal of Australia

Volumn 185, Issue 3, 2006, Pages 178-179

  van Daele, Paul L A ^a   Bakker, Marleen ^a   van Hagen, P Martin ^a   Bearsma, G Seerp ^b   Kuijpers, Robert W A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; BLURRED VISION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; EYE INFLAMMATION; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; LETTER; LYMPH NODE BIOPSY; MALE; NETHERLANDS; OPHTHALMOLOGY; PATIENT IDENTIFICATION; PATIENT REFERRAL; REMISSION; SYMPTOMATOLOGY; TUBERCULIN TEST; TUBERCULOSIS; UVEITIS; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

EID: 33747590105     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00515.x     Document Type: Letter

References (5)

1. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica 2004; 218: 223-236.
2. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992, 76: 137-141.
3. Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 2002; 109: 851-857.
4. Sheu SJ, Shyu JS, Chen LM, et al. Ocular manifestations of tuberculosis. Ophthalmology 2001; 108: 1580-1585.
5. Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005; 89: 533-536.